Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Molecular classification of mucoepidermoid carcinomas—Prognostic significance of the MECT1–MAML2 fusion oncogene
- A. Behboudi, F. Enlund, +9 authors G. Stenman
- Biology, Medicine
- Genes, chromosomes & cancer
- 1 May 2006
Mucoepidermoid carcinomas (MECs) of the salivary and bronchial glands are characterized by a recurrent t(11;19)(q21;p13) translocation resulting in a MECT1–MAML2 fusion in which the CREB‐binding… Expand
Prevalence and physical status of human papillomavirus in squamous cell carcinomas of the head and neck
- W. Koskinen, R. W. Chen, +10 authors L. Aaltonen
- Biology, Medicine
- International journal of cancer
- 10 November 2003
Fresh‐frozen biopsies were obtained from 61 patients at diagnosis of squamous cell carcinoma of the head and neck (HNSCC) for study of the prevalence and physical status of human papillomavirus (HPV)… Expand
Bmi-1 expression predicts prognosis in squamous cell carcinoma of the tongue
- V. Häyry, L. Mäkinen, +7 authors J. Hagström
- Biology, Medicine
- British Journal of Cancer
- 9 February 2010
Background:The prognosis of squamous cell carcinoma of the oral tongue is poor and it would be beneficial to find prognostic markers to better adjust treatment. Bmi-1 controls cell cycle and… Expand
COVID‐19 pandemic: Effects and evidence‐based recommendations for otolaryngology and head and neck surgery practice
- L. Kowalski, A. Sanabria, +19 authors A. Ferlito
- Medicine
- Head & neck
- 9 April 2020
The 2019 novel coronavirus disease (COVID‐19) is a highly contagious zoonosis produced by SARS‐CoV‐2 that is spread human‐to‐human by respiratory secretions. It was declared by the WHO as a public… Expand
Bacteriologic findings in peritonsillar abscesses in young adults.
- H. Jousimies-Somer, S. Savolainen, A. Mäkitie, J. Ylikoski
- Medicine
- Clinical infectious diseases : an official…
- 1 June 1993
Aspirated pus samples from 124 patients with peritonsillar abscess were cultured quantitatively for aerobes and anaerobes. A total of 98% of the samples yielded bacteria. Of the 550 isolates obtained… Expand
Accuracy of medical models made by additive manufacturing (rapid manufacturing).
- Mika Salmi, Kaija-Stiina Paloheimo, J. Tuomi, J. Wolff, A. Mäkitie
- Medicine
- Journal of cranio-maxillo-facial surgery…
- 1 October 2013
BACKGROUND
Additive manufacturing (AM) is being increasingly used for producing medical models. The accuracy of these models varies between different materials, AM technologies and machine runs.
… Expand
Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.
- A. Mäkitie, C. Macmillan, +14 authors S. Kamel-Reid
- Biology, Medicine
- Clinical cancer research : an official journal of…
- 1 June 2003
PURPOSE
p16 is an important inhibitor of cell cycle progression; absence of p16 can thus result in increased cellular proliferation. In nasopharyngeal carcinoma (NPC), absence of p16 has been… Expand
Pharyngocutaneous fistula following total laryngectomy: a single institution’s 10-year experience
- A. Mäkitie, R. Niemensivu, +5 authors T. Atula
- Medicine
- European Archives of Oto-Rhino-Laryngology and…
- 21 September 2006
The etiology of postoperative pharyngocutaneous fistula (PCF) formation following major head and neck surgery is multifactorial and the incidence varies greatly. We reviewed retrospectively the… Expand
Boron neutron capture therapy in the treatment of locally recurred head-and-neck cancer: final analysis of a phase I/II trial.
- L. Kankaanranta, T. Seppälä, +17 authors H. Joensuu
- Medicine
- International journal of radiation oncology…
- 2012
PURPOSE
To investigate the efficacy and safety of boron neutron capture therapy (BNCT) in the treatment of inoperable head-and-neck cancers that recur locally after conventional photon radiation… Expand
The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck
- P. Alhopuro, S. K. Ylisaukko-oja, +12 authors L. Aaltonen
- Biology, Medicine
- Journal of Medical Genetics
- 1 September 2005
Background: MDM2 acts as a principal regulator of the tumour suppressor p53 by targeting its destruction through the ubiquitin pathway. A polymorphism in the MDM2 promoter (SNP309) was recently… Expand